🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Teva is developing 40 mg/ml Glatiramer Acetate (GA) Injection , administere...
Status
Completed
Location
Teva Benelux
Start Date
2006-07-27
Trial ID
NCT00326625
Treatments Being Tested
This is an open-label, randomized, multi-center, parallel-arm study to asse...
Status
Completed
Location
Teva Investigational Site 10706
Start Date
2013-06
Trial ID
NCT01874145
Treatments Being Tested
Teva is developing a 40 mg/ml GA Injection, administered once daily under t...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00337779
Treatments Being Tested
This is a phase IIa study with GA Depot in subjects with Primary Progressiv...
Status
Terminated
Location
Mapi Pharma Research site 09
Start Date
2017-12-11
Trial ID
NCT03362294
Treatments Being Tested
* This is a phase IIa study in which GA Depot 80 or 40mg is administered as...
Status
Completed
Location
Barzilai Medical Center
Start Date
2014-10
Trial ID
NCT02212886
Treatments Being Tested
The study is designed to assess the efficacy of Glatiramer Acetate (GA) inj...
Status
Completed
Location
Teva Investigational Site 1332
Start Date
2010-06-22
Trial ID
NCT01067521
Treatments Being Tested